Telmisartan treatment showed a trend to reduced GFR, and combined treatment showed significantly lower GFR, despite lower levels of albuminuria with these treatments than with ramipril ( 30 ), arguing against the hypothesis that albuminuria can be used as a marker of nephroprotection.
1
—
—